Cellectis S.A. Statistics
NASDAQ: CLLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.34-0.06 (-4.29%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cellectis S.A. by the numbers
Cellectis S.A. has a market capitalization of $135.0 million based on 72.72M shares outstanding. With trailing EPS of $-0.64, Cellectis S.A. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 47.4% below its 50-day average and 60.4% below its 200-day average.
Average daily trading volume is 78.85K shares, or about $105,655 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CLLS valuation vs. peer median
| Metric | CLLS | Peer median | Difference |
|---|---|---|---|
| Market cap | $134.96M | $132.57M | +2% |
| Avg. volume | 78.85K | 624.65K | -87% |
Peer median across 8 companies: RNA, OGI, TLSA, TNXP, SPRB, HURA, SDEV, NRXP.
Valuation
- Market cap
- $134.96M
- EPS (TTM)
- $-0.64
- Shares outstanding
- 72.72M
Price and trading
- Previous close
- 1.40
- Open
- 1.35
- Day range
- 1.33 – 1.40
- 52-week range
- 1.25 – 5.48
- 52-week change
- -64.92%
- Beta
- —
- Volume
- 62.43K
- Average volume
- 78.85K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 134.96M
- Forward Pe
- -2.16
- Eps
- -0.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.48
- Week52 Low
- 1.25
- Avg Volume
- 78,847.00
- Shares Outstanding
- 72.72M
- Ma50
- 2.55
- Ma200
- 3.38
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -75.55%
- Pct From52w Low
- 7.20%